Talk Highlights:
- Therapies such as low-dose naltrexone, intermittent fasting, and targeted detoxification show promise when utilizing specific biomarkers to measure patient outcomes
- Long COVID's heterogeneous nature explains mixed clinical trial results and demands personalized treatment approaches for effectiveness
- Potential new treatments such as rapamycin can help address emerging challenges in managing mitochondrial function
back to schedule
RETURN TO SCHEDULE
Day 1 Curated Lineup
Long COVID and the Chronic Fatigue Connection (70 min)
Paul Anderson, ND
Brain-Gut Connection in Long COVID Recovery (50 min)
Peter Kan, DC, DACNB, FAAIM
Long COVID in Women: Hormonal and Autonomic Effects (62 min)
Jessica Drummond, DCN, CNS, PT, NBC-HWC
Promising Long COVID Treatment Trials (60 min)
Gez Medinger
ME/CFS Research and Treatment Insights (51 min)
Patrick Ussher
The Septad Model for ME/CFS and Long COVID [PRO LEVEL] (52 min)
David Kaufman, MDDay 1 - Bonus Content
How to Diagnose Long COVID (37 min)
Nafysa Parpia, ND
ME/CFS Frequently Asked Questions (7 min)
Jamie Kunkle, NDLong COVID Frequently Asked Questions (8 min)
Jamie Kunkle, NDAbout the Expert
Gez Medinger
WebsiteGez Medinger is an investigative science journalist and patient advocate for Long Covid. He was a film-maker and marathon runner when he became ill with Covid in the early days of the pandemic. When he didn't recover, Gez put his efforts into researching the novel condition of Long Covid, interviewing some of the world's leading clinicians and turning his YouTube channel into a huge resource for patients, conducting over a dozen patient led studies - which have been quoted in global press including New York Times, New Scientist and Men's Health. In the process he has built a worldwide community and his films currently have over 5 million views
Gain Access to Exclusive Offers From Our Sponsors
